Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
13m agoTimberland Bancorp Reports Second Fiscal Quarter Net Income of $7.1 Million
39m agoCPKC increases dividend by 17.5 percent
39m agoWaldencast announces conclusion of SEC investigation
40m agoNektar to Announce Financial Results for the First Quarter on Thursday, May 7, 2026, After Close of U.S.-Based Financial Markets
40m agoF5 to Host Analyst and Investor Meeting on May 28, 2026
Immatics Nv logo

Immatics Nv

About

Immatics Nv (NASDAQ:IMTX) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 21 2026
Immatics Announces Four Upcoming Oral Presentations Across Its Clinical Cell Therapy and Bispecific Portfolio at 2026 ASCO Annual Meeting
Apr 17 2026
PRAME-directed Cell Therapy Using Immatics’ TCR Induces Deep and Durable Remission in Pediatric Patient with Advanced Metastatic Nephroblastoma
Mar 5 2026
Immatics Announces Full Year 2025 Financial Results and Business Update
Dec 11 2025
Immatics Presents IMA203CD8 PRAME Cell Therapy Data from Ongoing Dose Escalation and Shows Promising Initial Anti-tumor Activity in PRAME-Positive Tumors at ESMO-IO 2025 Congress
Dec 5 2025
Immatics Announces $125 Million Underwritten Offering

Financials

Revenue
$48.27 M
Market Cap
$1.39 B
EPS
-1.86

Community Chat

Ask AI

6ix6ixAIEvents